Gastrointestinal Neoplasm Clinical Trial
Official title:
Clinical Trial of Efficacy and Safety of Fengh Disposable Powered Articulating Endoscopic Linear Cutter Stapler Used for Gastrointestinal Tissue Cutting and Anastomosis
Verified date | November 2023 |
Source | Fengh Medical Co., Ltd. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To evaluate whether the anastomosis success rate of the main effectiveness evaluation indexes is not inferior to the similar products produced by Johnson & Johnson when the Fengh Disposable Powered Articulating Endoscopic Linear Cutter Stapler Used for Gastrointestinal Tissue Cutting and Anastomosis
Status | Completed |
Enrollment | 164 |
Est. completion date | January 20, 2022 |
Est. primary completion date | February 11, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility | Inclusion Criteria: 1. The subjects are 18 ~ 75 years old, regardless of gender: 2. Subjects need to use a linear stapler for gastrointestinal tissue cutting and anastomosis: 3. The subject or his legal representative can understand the purpose of the study and show sufficient compliance with the study protocol And sign informed consent. Exclusion Criteria: 1. The subject plans to perform emergency gastrointestinal surgery: 2. Subjects with moderate malnutrition (BML < 17kg / m2) and severe anemia (HB < 60g / L): 3. Subject BMI 228kg / m2; 4. Subject platelet (PLT) < 60x 109 / L or international normalized ratio (INR) > 1.5; 5. Subject forced expiratory volume per second (FEV1) / expected value = 50%, or forced expiratory volume per second (FEV1) / forced vital capacity (FCV) < 60%; 6. Subject's cardiac ejection fraction = 50%; 7. Have important organ failure or other serious diseases (e.g. preoperative subject aspartate amino acid) Transferase (AST), or alanine aminotransferase (ALT), or serum creatinine (SER) exceeds normal values Upper limit 3 times and above: subjects with fasting blood glucose value > 10.0mmol/l before operation: 8. The subjects were pregnant or lactating women; Page 16 of 53 Version No.: 1.1/version date 20190125 Clinical trial on the efficacy and safety of linear cutting stapler and components for disposable electric endoscopy for cutting and anastomosis of gastrointestinal tissue 9. Subjects participated in clinical trials of other drugs or devices within 3 months before the trial; 10. Other conditions that the researchers judged not suitable for inclusion. |
Country | Name | City | State |
---|---|---|---|
China | Disposable Powered Articulating Endoscopic Linear Cutter Stapler | Jiangyin | Jiangsu |
Lead Sponsor | Collaborator |
---|---|
Fengh Medical Co., Ltd. |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of Participants With Anastomosis Success | The transection and anastomosis of lung tissues are performed during the operation. The device is withdrawn after successful triggering. The cutting staple line is carefully checked for integrity, air leakage and bleeding. Anastomosis is considered as successful if all anastomotic rings are intact without leakage or bleeding, otherwise it is considered as failure. If necessary, the gas injection method is used to inspect whether there is bubble overflow at anastomotic stoma. If there is no bubble overflow, it is recorded as successful anastomosis; if there is obvious bubble overflow, it is recorded as anastomosis failure. | During surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Approved for marketing |
NCT00094029 -
A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248
|
N/A | |
Not yet recruiting |
NCT06134687 -
Novel Rigidizing Overtube in Colonic Endoscopic Submucosal Dissection
|
N/A | |
Completed |
NCT01621295 -
Assessing the Patient Experience in Cancer Care
|
N/A | |
Withdrawn |
NCT03538613 -
Study of People With Metastatic Gastrointestinal Epithelial Cancer Administering Tumor-Infiltrating Lymphocytes in Which the Gene Encoding CISH Was Inactivated Using the CRISPR/Cas9 System
|
Phase 1/Phase 2 | |
Completed |
NCT02785783 -
Endoringsā¢ Assisted Colonoscopy Versus Standard Colonoscopy for Polyp Detection
|
N/A | |
Completed |
NCT05172635 -
Primary Tumour Response to Induction Chemotherapy in Synchronously Metastasized Colorectal Cancer
|
||
Completed |
NCT01129310 -
First Line Study of Irinotecan, Capecitabine and Oxaliplatin in Metastatic Gastric or Gastroesophageal Cancer.
|
Phase 2 | |
Completed |
NCT03411915 -
A Study of XmAb®18087 in Subjects With NET and GIST
|
Phase 1 | |
Completed |
NCT00052962 -
Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal Carcinomatosis
|
Phase 3 | |
Recruiting |
NCT06159634 -
Traction vs. No Traction in Colonic ESD
|
N/A | |
Withdrawn |
NCT00640692 -
Kinase Genotyping of Gastro Intestinal Stomach Tumors (GISTs) From Patients Enrolled in Pfizer A6181112 Phase IIIb Trial
|
||
Completed |
NCT00465725 -
A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors
|
Phase 1 |